A randomized phase II trial of fludarabine/melphalan 140 vs fludarabine/melphalan 100 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma Meeting Abstract
| Authors: | Qazilbash, M.; Thall, P. F.; Liu, P.; Orlowski, R. Z.; Bashir, Q.; Shah, N.; Kebriaei, P.; Parmar, S.; Jones, R.; Hosing, C. M.; Popat, U. R.; Dinh, Y. T.; Rondon, G.; Shah, J. J.; de Lima, M.; Champlin, R.; Giralt, S. |
| Abstract Title: | A randomized phase II trial of fludarabine/melphalan 140 vs fludarabine/melphalan 100 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma |
| Meeting Title: | 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis |
| Journal Title: | Blood |
| Volume: | 118 |
| Issue: | 21 |
| Meeting Dates: | 2011 Dec 10-13 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2011-11-01 |
| Start Page: | 1754 |
| Language: | English |
| ACCESSION: | WOS:000299597106276 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V118.21.4108.4108 |
| Notes: | --- - Meeting Abstract: 4108 - 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) - DEC 10-13, 2011 - San Diego, CA - "Source: Wos" |
